Cargando…

Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran

BACKGROUND: Beta-thalassemia is considered to be the most frequent hereditary blood disorder worldwide. Lipid abnormalities have been detected in different types of beta-thalassemia. The aim of this study is to assess the lipid profiles in beta-thalassemia major (BTM) and beta-thalassemia intermedia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haghpanah, Sezaneh, Davani, Maryam, Samadi, Behrang, Ashrafi, Afsaneh, Karimi, Mehran
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082801/ https://www.ncbi.nlm.nih.gov/pubmed/21526074

Ejemplares similares

Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2015)

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea
por: Abolhasani Foroughi, Amin, et al.
Publicado: (2015)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2018)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

Major Causes of Hospital Admission in Beta Thalassemia Major Patients in Southern Iran
por: Karimi, Mehran, et al.
Publicado: (2011)

Frequency of Sensory Neural Hearing Loss in Major Beta-Thalassemias in Southern Iran
por: Faramarzi, Abolhassan, et al.
Publicado: (2010)

Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience
por: Safarpour, Mohammad Mostafa, et al.
Publicado: (2017)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran
por: Ansari-Moghaddam, Alireza, et al.
Publicado: (2018)

Epidemiologic study of patients with thrombotic events referred to a tertiary hospital in Southern Iran
por: Akbari, Ahmad, et al.
Publicado: (2021)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study
por: Bordbar, Mohammadreza, et al.
Publicado: (2017)

Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran
por: Karimi, Mehran, et al.
Publicado: (2016)

Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial
por: Ajami, Gholam-Hossein, et al.
Publicado: (2010)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Quality of Life in Patients with Thalassemia Major and Intermedia in Kerman-Iran (I.R.)
por: Safizadeh, Hossein, et al.
Publicado: (2012)

Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia
por: Majd, Zahra, et al.
Publicado: (2015)

Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia
por: Azarkeivan, Azita, et al.
Publicado: (2009)

The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity
por: Chen, Wanqun, et al.
Publicado: (2010)

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience
por: Karimi, Mehran, et al.
Publicado: (2021)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Adrenal Insufficiency in Patients with Beta-Thalassemia Major in the Southeast of Iran
por: Miri-Aliabad, Ghasem, et al.
Publicado: (2022)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Double heterozygocity for hemoglobin C and beta thalassemia dominant: A rare case of thalassemia intermedia
por: Agapidou, Alexandra, et al.
Publicado: (2018)

Corrigendum to “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq”
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis
por: Shariat, Abdolhamid, et al.
Publicado: (2013)

Evaluation of Mental Health and Related Factors among Patients with Beta-thalassemia Major in South East of Iran
por: Naderi, Majid, et al.
Publicado: (2012)

Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study
por: Karimi, Mehran, et al.
Publicado: (2020)

Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study
por: Hassanzadeh, Jafar, et al.
Publicado: (2017)

Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia
por: Shaalan, Mohammad G, et al.
Publicado: (2022)

Complications of patients with thalassemia major and intermedia in a selected Iranian population
por: Azizi, Vahid, et al.
Publicado: (2022)

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
por: Meloni, Antonella, et al.
Publicado: (2023)

Frequency of secondary modifiers in Beta Thalassemia intermedia in patients from Northern Punjab
por: Nasreen, Fariha, et al.
Publicado: (2023)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Investigating the trends of incidence rates of breast cancer in Southern Iran: a population based survey
por: Haghpanah, Sezaneh, et al.
Publicado: (2023)

Did the Proband Have Thalassemia Intermedia or Severe Thalassemia Trait?
por: Özsoylu, Şinasi
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h48cc6p8s8lvoen7unkiuv3ac6